These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3145266)

  • 1. Subpopulations of variants resistant to imipenem in Pseudomonas aeruginosa.
    Nilsson L; Nilsson M; Jendle J
    J Antimicrob Chemother; 1988 Nov; 22(5):643-9. PubMed ID: 3145266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.
    Rådberg G; Nilsson LE; Svensson S
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2142-7. PubMed ID: 2127345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of variants resistant to different aminoglycosides in Pseudomonas aeruginosa.
    Nilsson L; Sörén L; Rådberg G
    J Antimicrob Chemother; 1987 Aug; 20(2):255-9. PubMed ID: 3117761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G; Pozzetto B; Dorche G
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bactericidal activity of imipenem].
    Thabaut A; Meyran M
    Presse Med; 1990 Apr; 19(13):592-7. PubMed ID: 2139938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD; Wolter DJ
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002).
    Patzer JA; Dzierzanowska D
    Int J Antimicrob Agents; 2007 Feb; 29(2):153-8. PubMed ID: 17157481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
    Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
    Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro study of the bacteriostatic and bactericidal activity of meropenem against strains of Pseudomonas aeruginosa multiresistant to antibiotics].
    Delisle F; Lesage D; Barakett V; Richard G; Petit JC
    Pathol Biol (Paris); 1996 May; 44(5):337-40. PubMed ID: 8758471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of in vitro resistance to imipenem in Pseudomonas aeruginosa.
    Wolter EJ; Witte W
    J Basic Microbiol; 1990; 30(8):617-22. PubMed ID: 2129043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro emergence of beta-lactam-resistant variants of Pseudomonas aeruginosa.
    Eng RH; Smith SM; Cherubin CE
    J Antimicrob Chemother; 1986 Jun; 17(6):717-23. PubMed ID: 3090007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.
    Odenholt I; Isaksson B; Nilsson L; Cars O
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):136-41. PubMed ID: 2498095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.